[
  {
    "holder": "PDT Partners LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-07-27",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-07-24",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.79,
    "position_percent_raw": "0,79",
    "position_date": "2026-06-24",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2026-06-18",
    "comment": ""
  },
  {
    "holder": "PDT Partners LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2026-06-18",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.74,
    "position_percent_raw": "0,74",
    "position_date": "2026-06-12",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.97,
    "position_percent_raw": "0,97",
    "position_date": "2026-06-10",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.89,
    "position_percent_raw": "0,89",
    "position_date": "2026-06-05",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2026-06-02",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.11,
    "position_percent_raw": "1,11",
    "position_date": "2026-05-28",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.04,
    "position_percent_raw": "1,04",
    "position_date": "2026-05-26",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.9,
    "position_percent_raw": "0,9",
    "position_date": "2026-05-20",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.89,
    "position_percent_raw": "0,89",
    "position_date": "2026-05-19",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.07,
    "position_percent_raw": "1,07",
    "position_date": "2026-05-15",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.8,
    "position_percent_raw": "0,8",
    "position_date": "2026-05-12",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.9,
    "position_percent_raw": "0,9",
    "position_date": "2026-05-06",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2026-04-29",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.1,
    "position_percent_raw": "1,1",
    "position_date": "2026-04-27",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.01,
    "position_percent_raw": "1,01",
    "position_date": "2026-04-23",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.91,
    "position_percent_raw": "0,91",
    "position_date": "2026-04-22",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.87,
    "position_percent_raw": "0,87",
    "position_date": "2026-04-07",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.88,
    "position_percent_raw": "0,88",
    "position_date": "2026-04-02",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.71,
    "position_percent_raw": "0,71",
    "position_date": "2026-03-25",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.99,
    "position_percent_raw": "0,99",
    "position_date": "2026-03-24",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.08,
    "position_percent_raw": "1,08",
    "position_date": "2026-03-20",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2026-03-18",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.62,
    "position_percent_raw": "0,62",
    "position_date": "2026-03-16",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.1,
    "position_percent_raw": "1,1",
    "position_date": "2026-03-11",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.52,
    "position_percent_raw": "0,52",
    "position_date": "2026-03-09",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.0,
    "position_percent_raw": "1",
    "position_date": "2026-02-27",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2026-02-25",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.9,
    "position_percent_raw": "0,9",
    "position_date": "2026-02-18",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2026-02-18",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.84,
    "position_percent_raw": "0,84",
    "position_date": "2026-02-16",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.77,
    "position_percent_raw": "0,77",
    "position_date": "2026-02-12",
    "comment": ""
  },
  {
    "holder": "GSA Capital Partners LLP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2026-02-11",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.89,
    "position_percent_raw": "0,89",
    "position_date": "2026-02-09",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.99,
    "position_percent_raw": "0,99",
    "position_date": "2026-01-28",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.97,
    "position_percent_raw": "0,97",
    "position_date": "2026-01-22",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.07,
    "position_percent_raw": "1,07",
    "position_date": "2026-01-14",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.99,
    "position_percent_raw": "0,99",
    "position_date": "2026-01-13",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.15,
    "position_percent_raw": "1,15",
    "position_date": "2026-01-07",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 1.0,
    "position_percent_raw": "1",
    "position_date": "2025-12-18",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.96,
    "position_percent_raw": "0,96",
    "position_date": "2025-12-17",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.82,
    "position_percent_raw": "0,82",
    "position_date": "2025-12-11",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.91,
    "position_percent_raw": "0,91",
    "position_date": "2025-12-10",
    "comment": ""
  },
  {
    "holder": "PDT Partners LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.62,
    "position_percent_raw": "0,62",
    "position_date": "2025-11-14",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.77,
    "position_percent_raw": "0,77",
    "position_date": "2025-11-11",
    "comment": ""
  },
  {
    "holder": "PDT Partners LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.51,
    "position_percent_raw": "0,51",
    "position_date": "2025-11-07",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.82,
    "position_percent_raw": "0,82",
    "position_date": "2025-11-07",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2025-11-06",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.74,
    "position_percent_raw": "0,74",
    "position_date": "2025-11-04",
    "comment": ""
  },
  {
    "holder": "Voleon Capital Management LP",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.62,
    "position_percent_raw": "0,62",
    "position_date": "2025-10-30",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2025-10-24",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.66,
    "position_percent_raw": "0,66",
    "position_date": "2025-10-03",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.8,
    "position_percent_raw": "0,8",
    "position_date": "2025-09-22",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2025-08-25",
    "comment": ""
  },
  {
    "holder": "Arrowstreet Capital Limited Partnership",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-08-19",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.61,
    "position_percent_raw": "0,61",
    "position_date": "2025-07-23",
    "comment": ""
  },
  {
    "holder": "Arrowstreet Capital Limited Partnership",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.53,
    "position_percent_raw": "0,53",
    "position_date": "2025-07-17",
    "comment": ""
  },
  {
    "holder": "Spark Investment Management LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-06-27",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.52,
    "position_percent_raw": "0,52",
    "position_date": "2025-06-27",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-06-26",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-06-17",
    "comment": ""
  },
  {
    "holder": "Spark Investment Management LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.56,
    "position_percent_raw": "0,56",
    "position_date": "2025-05-02",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-05-02",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2025-04-28",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-04-25",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-04-25",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.58,
    "position_percent_raw": "0,58",
    "position_date": "2025-04-09",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.68,
    "position_percent_raw": "0,68",
    "position_date": "2025-04-01",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.79,
    "position_percent_raw": "0,79",
    "position_date": "2025-03-21",
    "comment": ""
  },
  {
    "holder": "Citadel Advisors LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.51,
    "position_percent_raw": "0,51",
    "position_date": "2025-03-11",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.87,
    "position_percent_raw": "0,87",
    "position_date": "2025-03-10",
    "comment": ""
  },
  {
    "holder": "Connor Clark & Lunn Investment Management Ltd.",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2025-03-10",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.92,
    "position_percent_raw": "0,92",
    "position_date": "2025-03-06",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2025-03-04",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2025-02-28",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-02-28",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.67,
    "position_percent_raw": "0,67",
    "position_date": "2025-02-20",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2025-02-17",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.62,
    "position_percent_raw": "0,62",
    "position_date": "2025-02-13",
    "comment": ""
  },
  {
    "holder": "WORLDQUANT LLC",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.52,
    "position_percent_raw": "0,52",
    "position_date": "2025-02-11",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-02-07",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2025-01-28",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": null,
    "position_percent_raw": "<0,5",
    "position_date": "2025-01-22",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.59,
    "position_percent_raw": "0,59",
    "position_date": "2025-01-10",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.69,
    "position_percent_raw": "0,69",
    "position_date": "2025-01-02",
    "comment": ""
  },
  {
    "holder": "ActusRayPartners Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.5,
    "position_percent_raw": "0,5",
    "position_date": "2024-12-17",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.79,
    "position_percent_raw": "0,79",
    "position_date": "2024-12-05",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.81,
    "position_percent_raw": "0,81",
    "position_date": "2024-11-29",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.7,
    "position_percent_raw": "0,7",
    "position_date": "2024-11-18",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.6,
    "position_percent_raw": "0,6",
    "position_date": "2024-10-25",
    "comment": ""
  },
  {
    "holder": "Qube Research & Technologies Limited",
    "issuer": "Hansa Biopharma AB",
    "isin": "SE0002148817",
    "position_percent": 0.51,
    "position_percent_raw": "0,51",
    "position_date": "2024-10-07",
    "comment": ""
  }
]